Nadja A. Vielot

542 total citations
46 papers, 329 citations indexed

About

Nadja A. Vielot is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Nadja A. Vielot has authored 46 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 20 papers in Infectious Diseases and 9 papers in Health. Recurrent topics in Nadja A. Vielot's work include Viral gastroenteritis research and epidemiology (17 papers), Cervical Cancer and HPV Research (14 papers) and Vaccine Coverage and Hesitancy (9 papers). Nadja A. Vielot is often cited by papers focused on Viral gastroenteritis research and epidemiology (17 papers), Cervical Cancer and HPV Research (14 papers) and Vaccine Coverage and Hesitancy (9 papers). Nadja A. Vielot collaborates with scholars based in United States, Nicaragua and South Africa. Nadja A. Vielot's co-authors include Sylvia Becker‐Dreps, Jennifer S. Smith, Kim Longfield, Anne M. Butler, M. Alan Brookhart, Filemón Bucardo, Ralph S. Baric, Rob Gray, Brian Smith and Fredman González and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Nadja A. Vielot

38 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadja A. Vielot United States 10 137 130 53 49 44 46 329
Pablo Kuri Mexico 12 124 0.9× 165 1.3× 73 1.4× 87 1.8× 100 2.3× 22 441
Mira Kojouharova Bulgaria 13 138 1.0× 219 1.7× 137 2.6× 39 0.8× 44 1.0× 24 417
Benito Salvatierra Mexico 8 147 1.1× 124 1.0× 31 0.6× 20 0.4× 48 1.1× 19 376
Pushpa Ranjan Wijesinghe India 9 117 0.9× 144 1.1× 97 1.8× 40 0.8× 45 1.0× 18 306
Jiunn‐Yih Su Australia 13 100 0.7× 190 1.5× 56 1.1× 119 2.4× 131 3.0× 31 512
Pedro Plans-Rubió Spain 14 132 1.0× 326 2.5× 256 4.8× 33 0.7× 40 0.9× 27 545
J. Stevenson United Kingdom 11 122 0.9× 149 1.1× 96 1.8× 84 1.7× 15 0.3× 29 447
Marco Fonzo Italy 11 225 1.6× 205 1.6× 209 3.9× 39 0.8× 66 1.5× 47 532
Patricia Stinchfield United States 7 121 0.9× 174 1.3× 171 3.2× 16 0.3× 36 0.8× 15 319
W. William Schluter United States 13 164 1.2× 195 1.5× 111 2.1× 38 0.8× 124 2.8× 26 436

Countries citing papers authored by Nadja A. Vielot

Since Specialization
Citations

This map shows the geographic impact of Nadja A. Vielot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadja A. Vielot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadja A. Vielot more than expected).

Fields of papers citing papers by Nadja A. Vielot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadja A. Vielot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadja A. Vielot. The network helps show where Nadja A. Vielot may publish in the future.

Co-authorship network of co-authors of Nadja A. Vielot

This figure shows the co-authorship network connecting the top 25 collaborators of Nadja A. Vielot. A scholar is included among the top collaborators of Nadja A. Vielot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadja A. Vielot. Nadja A. Vielot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vielot, Nadja A., Yaoska Reyes, Natalie M. Bowman, et al.. (2025). Human milk oligosaccharides and Campylobacter jejuni and Campylobacter coli gastroenteritis risk in a Nicaraguan Birth Cohort. American Journal of Clinical Nutrition. 122(2). 488–501.
2.
3.
Vielot, Nadja A. & Noel T. Brewer. (2024). Optimizing Cancer Prevention in Adolescents by Improving HPV Vaccine Delivery. North Carolina Medical Journal. 85(1). 33–36.
4.
Bode, Lars, Jan Vinjé, Samuel Vilchez, et al.. (2024). Epidemiology of Pediatric Astrovirus Gastroenteritis in a Nicaraguan Birth Cohort. Open Forum Infectious Diseases. 11(9). ofae465–ofae465. 2 indexed citations
5.
Bucardo, Filemón, Michael L. Mallory, Fredman González, et al.. (2024). Charting the Impact of Maternal Antibodies and Repeat Exposures on Sapovirus Immunity in Early Childhood From a Nicaraguan Birth Cohort. The Journal of Infectious Diseases. 231(2). 480–489. 2 indexed citations
6.
Vielot, Nadja A., et al.. (2024). Transmission Patterns of Norovirus From Infected Children to Household Members in León, Nicaragua. Journal of the Pediatric Infectious Diseases Society. 13(2). 148–151. 1 indexed citations
7.
8.
Vielot, Nadja A., Yaoska Reyes, Fredman González, et al.. (2023). Household Surveillance for Norovirus Gastroenteritis in a Nicaraguan Birth Cohort: A Nested Case—Control Analysis of Norovirus Risk Factors. Pathogens. 12(3). 505–505. 2 indexed citations
9.
10.
Vielot, Nadja A., Fredman González, Yaoska Reyes, et al.. (2022). Association between breastfeeding, host genetic factors, and calicivirus gastroenteritis in a Nicaraguan birth cohort. PLoS ONE. 17(10). e0267689–e0267689. 6 indexed citations
11.
Vielot, Nadja A., Amanda Brinkman, Christina R. DeMaso, et al.. (2022). Breadth and Dynamics of Human Norovirus-Specific Antibodies in the First Year of Life. Journal of the Pediatric Infectious Diseases Society. 11(10). 463–466. 4 indexed citations
12.
Brewer-Jensen, Paul D., Yaoska Reyes, Sylvia Becker‐Dreps, et al.. (2022). Norovirus Infection in Young Nicaraguan Children Induces Durable and Genotype-Specific Antibody Immunity. Viruses. 14(9). 2053–2053. 5 indexed citations
13.
Narowski, Tara M., Lily E. Adams, Nadja A. Vielot, et al.. (2022). SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people. Cell Reports. 38(5). 110336–110336. 32 indexed citations
14.
15.
Vielot, Nadja A., Jennifer L. Lund, David J. Weber, et al.. (2022). Patterns of use of recombinant zoster vaccine among commercially-insured immunocompetent and immunocompromised adults 50–64 years old in the United States. Vaccine. 41(1). 49–60. 4 indexed citations
16.
Vielot, Nadja A., et al.. (2020). Awareness, Knowledge, and Travel-Related Risk Factors for Zika Virus Among Latinas Attending a Federally Qualified Health Center in Rural North Carolina. North Carolina Medical Journal. 81(1). 14–22. 3 indexed citations
17.
Vielot, Nadja A., et al.. (2019). Rectovaginal group B streptococcus colonization among pregnant women in Nicaragua: a systematic review and meta-analysis. The Journal of Maternal-Fetal & Neonatal Medicine. 34(15). 2418–2426. 2 indexed citations
18.
Vielot, Nadja A., et al.. (2019). Association of State Legislation of Human Papillomavirus Vaccination with Vaccine Uptake Among Adolescents in the United States. Journal of Community Health. 45(2). 278–287. 7 indexed citations
19.
Cameron, Jennifer, Anne F. Rositch, Nadja A. Vielot, et al.. (2018). Epstein-Barr Virus, High-Risk Human Papillomavirus and Abnormal Cervical Cytology in a Prospective Cohort of African Female Sex Workers. Sexually Transmitted Diseases. 45(10). 666–672. 13 indexed citations
20.
Vielot, Nadja A., Anne M. Butler, M. Alan Brookhart, Sylvia Becker‐Dreps, & Jennifer S. Smith. (2017). Patterns of Use of Human Papillomavirus and Other Adolescent Vaccines in the United States. Journal of Adolescent Health. 61(3). 281–287. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pablo Kuri Breakdown of academic impact, for papers by Mira Kojouharova Breakdown of academic impact, for papers by Benito Salvatierra Breakdown of academic impact, for papers by Pushpa Ranjan Wijesinghe Breakdown of academic impact, for papers by Jiunn‐Yih Su Breakdown of academic impact, for papers by Pedro Plans-Rubió Breakdown of academic impact, for papers by J. Stevenson Breakdown of academic impact, for papers by Marco Fonzo Breakdown of academic impact, for papers by Patricia Stinchfield Breakdown of academic impact, for papers by W. William Schluter
Rankless by CCL
2026